Post-traumatic stress disorder (PTSD) occurs only in vulnerable individuals after exposure to severe traumatic events. This risk is due, in part, to 30-40% heritability of differential vulnerability or resilience. The previous period of this NIMH-supported project has involved a genome-wide association study (GWAS) involving over 8,000 subjects focusing on identifying genetic pathways associated with PTSD. Furthermore, our group has been at the lead in forming the Psychiatric GWAS Consortium (PGC) PTSD working group, which has now recruited sharing from approximately 20 investigators worldwide, which will result in GWAS samples for ~10,000 cases and ~25,000 controls by 2015. It is thus a very exciting time for discovering the underlying genetic risk factors contributing to PTSD. However, most successful GWAS analyses to date suggest that risk arises from multiple common variants of small effect size, such that cumulative polygenic risk may be the most powerful approach to understanding risk vs. resilience following trauma. Now that we are in the realm of large scale consortia genetics, multiple genes of small effect size are likely to be identified as contributingto PTSD. Approaches are needed to understand the function of these combined risk variants to inform our understanding of and therapeutic intervention for PTSD. We will first characterize variants that associate with PTSD from our own GWA studies and consortium- based data. We will then map these genetic markers onto gene regulation related to stress and relevant for fear processing followed by examination of physiological and neural intermediate phenotypes. We will accomplish this through the following specific aims:
Aim 1 will identify GWAS candidates and polygenic risk score (PGRS) markers for PTSD from the GTP and PGC-PTSD cohorts.
Aim 2 will examine the association of genetic variants and PGRS for PTSD with altered gene expression in the brain, in cells in response to stress, and in neuronally-differentiated iPSCs. Finally, Aim 3 will examine the association of specific genetic variants and PGRS for PTSD with neural intermediate phenotypes related to stress and fear physiology. We hypothesize that this approach will identify polygenic risk that is associated with PTSD and its intermediate phenotypes of stress and fear physiology and amygdala function. Furthermore, we hypothesize that these cumulative genetic risk factors will have identifiable molecular and electro-physiological signatures in inducible pluripotent stem cell (iPSC)-derived human neurons that point to molecular underpinnings of PTSD vulnerability vs. resilience. Understanding the genetic architecture of PTSD and its intermediate phenotypes will lead to neurobiological insight, enhanced prevention, and improved treatment of this debilitating and prevalent syndrome.

Public Health Relevance

Up to 40% of the variance determining who develops Posttraumatic Stress Disorder following a severe trauma is genetically heritable. However, most successful analyses to date suggest that risk arises from multiple common genetic variants of small effect size. This application aims to examine the mechanisms by which polygenic risk is transformed into differential functional neural processes that underlie PTSD. Identifying the genetic pathways involved with PTSD, combined with our increasing understanding of the neural circuitry of fear and stress- dysregulation, will lead to an improved neurobiological understanding, enhanced prevention, and improved treatment of this debilitating and prevalent syndrome.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56MH071537-11A1
Application #
9084930
Study Section
Behavioral Genetics and Epidemiology Study Section (BGES)
Program Officer
Tuma, Farris K
Project Start
2004-09-01
Project End
2016-06-30
Budget Start
2015-07-10
Budget End
2016-06-30
Support Year
11
Fiscal Year
2015
Total Cost
$148,262
Indirect Cost
$33,419
Name
Emory University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Smith, Alicia K; Jovanovic, Tanja; Kilaru, Varun et al. (2017) A Gene-Based Analysis of Acoustic Startle Latency. Front Psychiatry 8:117
Rahman, Akm Fazlur; Manatunga, Amita; Guo, Ying et al. (2017) A latent class analysis of PTSD symptoms among inner city primary care patients. J Psychiatr Res 98:1-8
Berg, Carla J; Haardörfer, Regine; McBride, Colleen M et al. (2017) Resilience and biomarkers of health risk in Black smokers and nonsmokers. Health Psychol 36:1047-1058
Maddox, S A; Kilaru, V; Shin, J et al. (2017) Estrogen-dependent association of HDAC4 with fear in female mice and women with PTSD. Mol Psychiatry :
Massa, Nick M; Duncan, Erica; Jovanovic, Tanja et al. (2017) Relationship between Toxoplasma gondii seropositivity and acoustic startle response in an inner-city population. Brain Behav Immun 61:176-183
Ratanatharathorn, Andrew; Boks, Marco P; Maihofer, Adam X et al. (2017) Epigenome-wide association of PTSD from heterogeneous cohorts with a common multi-site analysis pipeline. Am J Med Genet B Neuropsychiatr Genet 174:619-630
Wingo, A P; Almli, L M; Stevens, J S et al. (2017) Genome-wide association study of positive emotion identifies a genetic variant and a role for microRNAs. Mol Psychiatry 22:774-783
Mercer, K B; Dias, B; Shafer, D et al. (2016) Functional evaluation of a PTSD-associated genetic variant: estradiol regulation and ADCYAP1R1. Transl Psychiatry 6:e978
Donaldson, Z R; le Francois, B; Santos, T L et al. (2016) The functional serotonin 1a receptor promoter polymorphism, rs6295, is associated with psychiatric illness and differences in transcription. Transl Psychiatry 6:e746
Kilaru, V; Iyer, S V; Almli, L M et al. (2016) Genome-wide gene-based analysis suggests an association between Neuroligin 1 (NLGN1) and post-traumatic stress disorder. Transl Psychiatry 6:e820

Showing the most recent 10 out of 93 publications